Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.

The Dow Jones Industrial Average (DJIA), the S&P 500 and the Nasdaq Composite closed between 1.7 per cent and 2.2 per cent ...

We read all day so you don't have to. Sign up for CNN Business' newsletter for the top stories you need to know.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...